Page last updated: 2024-10-16

beta-alanine and Lupus Erythematosus, Systemic

beta-alanine has been researched along with Lupus Erythematosus, Systemic in 3 studies

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research Excerpts

ExcerptRelevanceReference
" A second woman with primary APS experienced ischemic arterial strokes and right transverse-sigmoid sinus thrombosis after conversion to rivaroxaban."7.80Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. ( Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE, 2014)
"Epistaxis resulted in severe anemia in an 89-year-old Caucasian woman under a therapy with dabigatran for 12 months because of atrial fibrillation."3.80Dabigatran-induced lupus temporarily preventing blood group determination. ( Finsterer, J; Krutisch, G; Stöllberger, C; Wolf, HM, 2014)
" A second woman with primary APS experienced ischemic arterial strokes and right transverse-sigmoid sinus thrombosis after conversion to rivaroxaban."3.80Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. ( Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE, 2014)
"Nocardial brain abscess, the most common presentation of nocardiosis in the central nervous system, is associated with a high mortality rate because of its delayed diagnosis and its unresponsiveness to the usual antibiotic therapy."1.32[Nocardial brain abscess: surgery and postoperative antibiotic therapy]. ( Mine, S; Nakazaki, M; Ozaki, H; Saeki, N; Yamakami, I; Yamaura, A; Yoneyama, T, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stöllberger, C1
Krutisch, G1
Finsterer, J1
Wolf, HM1
Schaefer, JK1
McBane, RD1
Black, DF1
Williams, LN1
Moder, KG1
Wysokinski, WE1
Yoneyama, T1
Yamakami, I1
Mine, S1
Saeki, N1
Yamaura, A1
Ozaki, H1
Nakazaki, M1

Other Studies

3 other studies available for beta-alanine and Lupus Erythematosus, Systemic

ArticleYear
Dabigatran-induced lupus temporarily preventing blood group determination.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:6

    Topics: Aged, 80 and over; Anemia; Antibodies, Antinuclear; Antithrombins; Atrial Fibrillation; Benzimidazol

2014
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction;

2014
[Nocardial brain abscess: surgery and postoperative antibiotic therapy].
    No shinkei geka. Neurological surgery, 2004, Volume: 32, Issue:5

    Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; beta-Alanine; Brain Abscess; Cefo

2004